Validity of Sentinel Lymphnode Biopsy After Neoadjuvant Chemotherapy Cancer Patients With Radiologically Positive Axillary Lymph Nodes

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

June 30, 2009

Study Completion Date

November 30, 2009

Conditions
Breast Cancer
Interventions
PROCEDURE

Sentinel lymph node biopsy

Sentinel lymph node biopsy after neoadjuvant chemotherapy for the patients with clinically positive-nodes at presentation

DRUG

Neoadjuvant chemotherapy

Neoadjuvant chemotherapy for breast cancer patients with clinically positive-node at initial diagnosis

PROCEDURE

complete axillary lymph node dissection

Complete axillary lymph node dissection after sentinel node biopsy for estimation of false-negative rate of sentinel node biopsy

PROCEDURE

positron emission tomography and ultrasonogram

Routine evaluation of axillary nodal status using 18-fluorodeoxyglucose positron emission tomography and ultrasonogram before and after chemotherapy

Trial Locations (1)

135270

Gangnam Severance Hospital, Seoul

All Listed Sponsors
lead

Gangnam Severance Hospital

OTHER

NCT01622478 - Validity of Sentinel Lymphnode Biopsy After Neoadjuvant Chemotherapy Cancer Patients With Radiologically Positive Axillary Lymph Nodes | Biotech Hunter | Biotech Hunter